Cryoglobulinaemia
Not recruitingStudy of Isatuximab for Patients with Type I Cryoglobulinemia
Study of Isatuximab for Patients with Type I Cryoglobulinemia
- Disease:Cryoglobulinaemia
- Substances:–
France- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study of Isatuximab for Patients with Type I Cryoglobulinemia
FranceStudy on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough
BelgiumStudy on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock
FranceStudy on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy
FranceStudy on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome
DenmarkStudy on Autologous Chondrocytes and Remestemcel for Knee Cartilage Lesions in Patients with Symptomatic Articular Cartilage Damage
The NetherlandsStudy of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
AustriaStudy of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera
AustriaStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
BelgiumStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
BelgiumStudy on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
AustriaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.